Cargando…
Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review
BACKGROUND: Current Alzheimer’s disease (AD) research initiatives focus on cognitively healthy individuals with biomarkers that are associated with the development of AD. It is unclear whether biomarker results should be returned to research participants and what the psychological, behavioral and so...
Autores principales: | Bemelmans, S. A. S. A., Tromp, K., Bunnik, E. M., Milne, R. J., Badger, S., Brayne, C., Schermer, M. H., Richard, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103503/ https://www.ncbi.nlm.nih.gov/pubmed/27832826 http://dx.doi.org/10.1186/s13195-016-0212-z |
Ejemplares similares
-
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals(2)
por: Milne, Richard, et al.
Publicado: (2018) -
Predictors of Willingness to Enroll in Hypothetical Alzheimer Disease Biomarker Studies that Disclose Personal Results
por: Erickson, Claire M., et al.
Publicado: (2022) -
IRB perspectives on obligations to disclose genetic incidental findings to research participants
por: Gliwa, Catherine, et al.
Publicado: (2015) -
The Framing of “Alzheimer’s Disease”: Differences Between Scientific and Lay Literature and Their Ethical Implications
por: Smedinga, Marthe, et al.
Publicado: (2020) -
To disclose, or not to disclose? Context matters
por: Rahimzadeh, Vasiliki, et al.
Publicado: (2015)